Inficon Holding AG (0QK5)
London Exchange · UK · prices in CHF · close of 23 Oct 2026
Key indicators
| Last close | CHF 160.80 |
|---|---|
| 52-week range | 91.10 – 204.00 |
| Return, 1 month / 3 months | −11.5% / −0.7% |
| Return, 1 year / 3 years | +67.6% / +73.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 33 |
| Volatility (1 year) | 43.4% |
| Worst drawdown (1 year) | -25.9% |
| Average daily value traded | 0.83M CHF |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Inficon Holding makes instruments and sensors used to measure and control vacuum and thin films. Its products include leak detectors, vacuum gauges, gas analyzers and deposition monitors, which are used in semiconductor manufacturing, coating processes, refrigeration and industrial production. Customers are mainly equipment makers and manufacturers that need precise measurement and process control. The company is based in Bad Ragaz, Switzerland, and serves industrial and research markets around the world.
The shares are listed on the London Exchange in UK under the code 0QK5, and the price on this page is in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Inficon Holding AG (0QK5) trades on the London Exchange in UK. It last closed at CHF 160.80 on 23 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,424 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 67.6% and over the last three months it fell 0.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.6% | ||
| From 52-week high | -20.8% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -0.7% | ||
| 6-month return | 28.6% | ||
| 12-month return, skipping the last month | 89.3% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.9% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.83M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 31 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −9.4% |
|---|---|
| 1 month | −11.5% |
| 3 months | −0.7% |
| 6 months | +28.6% |
| 1 year | +67.6% |
| 3 years | +73.1% |
| 5 years | +49.7% |
Signals
| 50-day / 200-day average | 175.67 / 149.46 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.10 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Apr 2026 | CHF 2.0000 |
| 10 Apr 2025 | CHF 21.0000 |
| 8 Apr 2024 | CHF 20.0000 |
| 4 Apr 2023 | CHF 18.0000 |
| 4 Apr 2022 | CHF 17.9000 |
| 6 Apr 2021 | CHF 16.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.